|
TMTC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.788400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.659500E-03 |
| Normal-vs-Stage2 |
5.441900E-03 |
| Normal-vs-Stage3 |
2.024300E-04 |
| Normal-vs-Stage4 |
3.521500E-03 |
| Stage1-vs-Stage2 |
6.185400E-01 |
| Stage1-vs-Stage3 |
2.477600E-01 |
| Stage1-vs-Stage4 |
6.501000E-01 |
| Stage2-vs-Stage3 |
7.163800E-01 |
| Stage2-vs-Stage4 |
9.289600E-01 |
| Stage3-vs-Stage4 |
6.236800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.923690E-03 |
| Normal-vs-AfricanAmerican |
3.206800E-01 |
| Normal-vs-Asian |
3.237900E-04 |
| Caucasian-vs-AfricanAmerican |
2.521600E-01 |
| Caucasian-vs-Asian |
2.248800E-01 |
| AfricanAmerican-vs-Asian |
5.348100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73911999999943E-05 |
| Normal-vs-Female |
8.264100E-03 |
| Male-vs-Female |
5.401100E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.761500E-04 |
| Normal-vs-Age(41-60Yrs) |
7.044600E-03 |
| Normal-vs-Age(61-80Yrs) |
3.621100E-04 |
| Normal-vs-Age(81-100Yrs) |
5.296100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.238200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.921000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.237400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.695200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.704200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.756000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.043800E-02 |
| Classical-VS-Follicular |
6.016400E-01 |
| Classical-VS-Other |
9.408800E-01 |
| Classical-VS-Normal |
4.989100E-04 |
| Tall-VS-Follicular |
9.828300E-02 |
| Tall-VS-Other |
5.989800E-01 |
| Tall-VS-Normal |
7.70490000000512E-05 |
| Follicular-VS-Other |
8.389600E-01 |
| Follicular-VS-Normal |
6.350100E-02 |
| Other-VS-Normal |
1.859760E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.761600E-04 |
| Normal-vs-N1 |
1.022120E-03 |
| N0-vs-N1 |
6.038600E-01 |
|
|
